Found 2 publications.
Displayed publications from 1 to 2
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 9122)
Briard B, Fontaine T, Samir P, Place DE, Muszkieta L, Malireddi RKS, Karki R, Christgen S, Bomme P, Vogel P, Beau R, Mellado E, Ibrahim-Granet O, Henrissat B, Kalathur RC, Robinson C, Latge JP, Kanneganti TD
Galactosaminogalactan activates the inflammasome to provide host protection
Nature 588(7839) (2020)
688-692
Inflammasomes are important sentinels of innate immune defence that are activated in response to diverse stimuli, including pathogen-associated molecular patterns (PAMPs). Activation of the inflammasome provides host defence against aspergillosis, which is a major health concern for patients who are immunocompromised. However, the Aspergillus fumigatus PAMPs that are responsible for inflammasome activation are not known. Here we show that the polysaccharide galactosaminogalactan (GAG) of A. fumigatus is a PAMP that activates the NLRP3 inflammasome. The binding of GAG to ribosomal proteins inhibited cellular translation machinery, and thus activated the NLRP3 inflammasome. The galactosamine moiety bound to ribosomal proteins and blocked cellular translation, which triggered activation of the NLRP3 inflammasome. In mice, a GAG-deficient Aspergillus mutant (Δgt4c) did not elicit protective activation of the inflammasome, and this strain exhibited enhanced virulence. Moreover, administration of GAG protected mice from colitis induced by dextran sulfate sodium in an inflammasome-dependent manner. Thus, ribosomes connect the sensing of this fungal PAMP to the activation of an innate immune response.
binding, PAMP, Aspergillus fumigatus, galactosaminogalactan, NLRP3 inflammasome
NCBI PubMed ID: 33268895Publication DOI: 10.1038/s41586-020-2996-zJournal NLM ID: 0410462Publisher: Basingstoke: Nature Publishing Group
Correspondence: Thirumala-Devi.Kanneganti

StJude.org
Institutions: Unité des Aspergillus, Institut Pasteur, Paris, France, Department of Immunology, St Jude Children's Research Hospital, Memphis, TN, USA, Ultrastructural Bio Imaging Unit, C2RT, Institut Pasteur, Paris, France, Animal Resources Center and the Veterinary Pathology Core, St Jude Children's Research Hospital, Memphis, TN, USA, Mycology Reference Laboratory, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Madrid, Spain, Unité des Cytokines et Inflammation, Institut Pasteur, Paris, France, AFMB, UMR 7257 CNRS, Aix-Marseille Université, Marseille, France, Department of Biological Sciences, King Abdulaziz University, Jeddah, Saudi Arabia, Department of Structural Biology, St Jude Children's Research Hospital, Memphis, TN, USA, Cell and Tissue Imaging Center, St Jude Children's Research Hospital, Memphis, TN, USA, Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece
Methods: methylation, deacetylation, PCR, GC-MS, acid hydrolysis, GLC, biological assays, MS, immunoblotting, acetylation, cloning, reduction, cell growth, immunofluorescence microscopy, cytokine production, adhesion assays, precipitation, phenol-sulfuric acid assay, spectrophotometry, SEM, centrifugation, qRT-PCR, filtration
The publication contains the following compound(s):
Expand this publication
Collapse this publication
2. (Article ID: 9262)
Chihara Y, Tanaka Y, Izumi M, Hagiwara D, Watanabe A, Takegawa K, Kamei K, Shibata N, Ohta K, Oka T
Biosynthesis of β-(1→5)-galactofuranosyl chains of fungal-type and O-mannose-type galactomannans within the invasive pathogen Aspergillus fumigatus
mSphere 5(1) (2020)
ID e00770-19
The pathogenic fungus Aspergillus fumigatus contains galactomannans localized on the surface layer of its cell walls, which are involved in various biological processes. Galactomannans comprise α-(1→2)-/α-(1→6)-mannan and β-(1→5)-/β-(1→6)-galactofuranosyl chains. We previously revealed that GfsA is a β-galactofuranoside β-(1→5)-galactofuranosyltransferase involved in the biosynthesis of β-(1→5)-galactofuranosyl chains. In this study, we clarified the biosynthesis of β-(1→5)-galactofuranosyl chains in A. fumigatus Two paralogs exist within A. fumigatus: GfsB and GfsC. We show that GfsB and GfsC, in addition to GfsA, are β-galactofuranoside β-(1→5)-galactofuranosyltransferases by biochemical and genetic analyses. GfsA, GfsB, and GfsC can synthesize β-(1→5)-galactofuranosyl oligomers at up to lengths of 7, 3, and 5 galactofuranoses within an established in vitro highly efficient assay of galactofuranosyltransferase activity. Structural analyses of galactomannans extracted from ΔgfsB, ΔgfsC, ΔgfsAC, and ΔgfsABC strains revealed that GfsA and GfsC synthesized all β-(1→5)-galactofuranosyl residues of fungal-type and O-mannose-type galactomannans and that GfsB exhibited limited function in A. fumigatus The loss of β-(1→5)-galactofuranosyl residues decreased the hyphal growth rate and conidium formation ability and increased the abnormal hyphal branching structure and cell surface hydrophobicity, but this loss is dispensable for sensitivity to antifungal agents and virulence toward immunocompromised mice. β-(1→5)-Galactofuranosyl residues are widely distributed in the subphylum Pezizomycotina of the phylum Ascomycota. Pezizomycotina includes many plant and animal pathogens. Although the structure of β-(1→5)-galactofuranosyl residues of galactomannans in filamentous fungi was discovered long ago, it remains unclear which enzyme is responsible for biosynthesis of this glycan. Fungal cell wall formation processes are complicated, and information concerning glycosyltransferases is essential for understanding them. In this study, we showed that GfsA and GfsC are responsible for the biosynthesis of all β-(1→5)-galactofuranosyl residues of fungal-type and O-mannose-type galactomannans. The data presented here indicate that β-(1→5)-galactofuranosyl residues are involved in cell growth, conidiation, polarity, and cell surface hydrophobicity. Our new understanding of β-(1→5)-galactofuranosyl residue biosynthesis provides important novel insights into the formation of the complex cell wall structure and the virulence of the members of the subphylum Pezizomycotina.
cell wall, galactofuranose, glycosyltransferase, glycosylation, Galactomannan, Aspergillus fumigatus, galactofuranosyltransferase
NCBI PubMed ID: 31941812Publication DOI: 10.1128/mSphere.00770-19Journal NLM ID: 101674533Publisher: Washington, DC: American Society for Microbiology
Correspondence: oka

bio.sojo-u.ac.jp
Institutions: Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Fukuoka, Japan, Medical Mycology Research Center, Chiba University, Chiba, Japan, Department of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, Kumamoto, Japan, Graduate School of Environmental and Life Science, Okayama University, Okayama, Japan, Department of Infection and Host Defense, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Methods: 13C NMR, 1H NMR, methylation, PCR, SDS-PAGE, DNA techniques, chemical synthesis, biological assays, enzymatic digestion, extraction, microscopy, acetylation, methylation analysis, reduction, CC, cell growth, dialysis, enzymatic assay, RNA extraction, adhesion assays, protein expression, gene disruption
The publication contains the following compound(s):
- Compound ID: 22525
|
b-D-Galf-(1-5)-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
- Compound ID: 22526
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G00052MO
- Compound ID: 22527
|
{{{-b-D-Galf-(1-5)-}}}/n=3/-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
- Compound ID: 22528
|
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
- Compound ID: 22529
|
{{{-b-D-Galf-(1-5)-}}}/n=5/-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
- Compound ID: 22530
|
{{{-b-D-Galf-(1-5)-}}}/n=6/-b-D-Galf-(1-7)-Subst
Subst = 4-methylumbelliferone, hymecromone = SMILES CC1=CC(OC2=C1C=C{7}C(O)=C2)=O |
Show graphically |
Structure type: oligomer
- Compound ID: 22531
|
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-6)-{{{-b-D-Galf-(1-5)-}}}/n=3/-b-D-Galf-(1-?)-+
|
-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1- |
Show graphically |
Structure type: structural motif or average structure
; n = 27-30
Compound class: polysaccharide, galactomannan
- Compound ID: 22532
|
a-D-Manp-(1-2)-+
|
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-6)-b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-D-Manp-(1--/(->3) L-Thr/L-Ser (protein)/ |
Show graphically |
Structure type: oligomer
Aglycon: (->3) L-Thr/L-Ser (protein)
- Compound ID: 22533
|
b-D-Galf-(1-?)-+
|
-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1- |
Show graphically |
Structure type: structural motif or average structure
; n = 27-30
Compound class: polysaccharide, galactomannan
Reference(s) to other database(s): GTC:G63746GD
- Compound ID: 22534
|
b-D-Galf-(1-6)-+
|
a-D-Manp-(1-2)-D-Manp-(1--/(->3) L-Thr/L-Ser (protein)/ |
Show graphically |
Structure type: oligomer
Aglycon: (->3) L-Thr/L-Ser (protein)
Reference(s) to other database(s): GTC:G44359GY
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: <1 sec